| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( Department of Surgery, The University of Chicago School of Medicine, Chicago, Illinois)
The suppression of 3-methylcholanthrene (3-MC)-induced mammary carcinoma in the white rat produced by triamcinolone diacetate was investigated by the quantitative analysis of the localization of 3-MC in the mammary gland of rats receiving triamcinolone diacetate as compared with rats not receiving this steroid. The analysis shows that there is no difference in the uptake of 3-MC in rats receiving triamcinolone diacetate. Levels of 3-MC in the mammary gland increase in direct proportion to the quantity of carcinogen fed. A single oral dose (50 mg.) disappears from the breast in 15 days in normal as well as in triamcinolone-treated rats. The results indicate that the suppression of mammary carcinoma produced by triamcinolone diacetate cannot be explained by the altered uptake or clearance of carcinogen by the mammary gland.
* This work was supported by grants from the Gladys Bowyer Foundation and Mr. Burr L. Robbins.
This article has been cited by other articles:
![]() |
T. Ohnishi, K. Fukamachi, Y. Ohshima, X. Jiegou, S. Ueda, M. Iigo, N. Takasuka, A. Naito, K.-i. Fujita, Y. Matsuoka, et al. Possible Application of Human c-Ha-ras Proto-Oncogene Transgenic Rats in a Medium-Term Bioassay Model for Carcinogens Toxicol Pathol, April 1, 2007; 35(3): 436 - 443. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |